Purdue Pharma and the Sackler family have agreed to a massive $74 billion opioid settlement. This historic deal is a significant step towards holding the pharmaceutical company accountable for its role in the opioid crisis.
The settlement is the largest of its kind in the US, and it's a major victory for victims of the opioid epidemic and their families. It's a long-overdue acknowledgment of the harm caused by Purdue Pharma's aggressive marketing of OxyContin.
The Sackler family, who own Purdue Pharma, will pay $6 billion of the settlement, while the company itself will pay $22.7 billion. This is a significant amount, considering the company's estimated worth is around $10 billion.
Intriguing read: Finance Purdue Plan of Study
Purdue Pharma Settlement Amounts
The Purdue Pharma settlement amounts are a significant part of the deal. A historic $7.4 billion dollar settlement has been reached with the company, which is a major step towards addressing the opioid crisis.
The settlement includes $850 million to be distributed among those who were affected by the opioid epidemic. This amount may seem like a lot, but when divided among the people who say they were addicted or lost loved ones, it's sliced thin.
Only people who drop their lawsuits can participate in the settlement and benefit financially from it. Those who want to keep their lawsuits going can still do so.
The Sackler family, who own Purdue Pharma, could still face a lot of litigation from individuals who say they were harmed.
Intriguing read: Purdue Pharma Family
US Settlement Details
The US settlement with Purdue Pharma is a $7.4 billion dollar deal, a historic and national agreement that's been reached after a prior settlement was struck down by the Supreme Court.
The deal allows only those who drop their lawsuits to participate and benefit financially, while those who choose to keep their lawsuits going can still pursue their cases in court.
A total of $850 million will be distributed, but when divided among all those affected, the payouts will be relatively small, with some people receiving hundreds or a few thousand dollars.
The Sackler family, who own Purdue Pharma, could still face a lot of litigation from individuals who claim they were harmed by the company's opioid products.
The deal is expected to go through, but anything can happen in a complex agreement like this.
Consider reading: National Mortgage Settlement Agreement
Settlement Impact
This settlement is a significant step towards accountability for the opioid crisis.
The deal is worth $7.4 billion, a historic amount that will be distributed to those affected by the crisis.
Only people who drop their lawsuits can participate in the settlement and benefit financially, but individuals can still choose to continue their lawsuits in court.
The Sackler family, owners of Purdue Pharma, may still face a lot of litigation from individuals who claim they were harmed.
States and U.S. territories have signed on to the deal, but some individuals may be disappointed with the payout, which could be as low as a few hundred dollars.
The settlement includes $850 million, but this amount is divided among a large number of people, resulting in small payouts for many.
Curious to learn more? Check out: A Viatical Settlement Broker May Not
Featured Images: pexels.com
